43rd EDRN Steering Committee Meeting (Main)
Agenda
Monday, September 23, 2024 (6:30 p.m. – 9:00 p.m.)
Central Daylight Time | Agenda Item |
---|---|
6:30 p.m. – 7:00 p.m. |
Sign-In: Room: Truhlsen Events Center Foyer Presentations: Truhlsen Events Center, Room: 1001 A |
7:00 p.m. – 9:00 p.m. |
Foundational Talks with Guest Presenters from University of Nebraska |
7:00 p.m. – 7:05 p.m. |
Welcome
|
7:05 p.m. – 7:20 p.m. 7:20 p.m. – 7:25 p.m. Q&A |
Pancreatic Cancer
|
7:25 p.m. – 7:40 p.m. 7:40 p.m. – 7:45 p.m. Q&A |
Prostate Cancer
|
7:45 p.m. – 8:00 p.m. 8:00 p.m. – 8:05 p.m. Q&A |
Colorectal Cancer
Member, Fred & Pamella Buffett Cancer Center, University of Nebraska Medical Center, Omaha |
8:05 p.m. – 8:20 p.m. 8:20 p.m. – 8:25 p.m. Q&A |
Lung Cancer
|
8:25 p.m. – 8:40 p.m. 8:40 p.m. – 8:45 p.m. Q&A |
Breast Cancer
|
8:45 p.m. – 9:00 p.m. |
Discussion/Networking |
9:00 p.m. |
Adjourn |
Tuesday, September 24, 2024 (7:00 a.m. – 8:00 p.m.)
Central Daylight Time | Agenda Item |
---|---|
7:00 a.m. – 8:00 a.m. |
Sign-in Room: Truhlsen Events Center Foyer General Session: Truhlsen Events Center, Room 1001 A |
8:00 a.m. – 8:05 a.m. |
Opening of Steering Committee Meeting and Approval of 42nd EDRN Steering Committee Meeting Minutes
|
8:05 a.m. – 8:15 a.m. |
Welcome
|
8:15 a.m. – 8:30 a.m. 8:30 a.m. – 8:40 a.m. Q&A |
State of the EDRN
|
8:40 a.m. – 9:00 a.m. 9:00 a.m. – 9:10 a.m. Q&A |
Vision for Population Sciences and Cancer Prevention at the Fred and Pamela Buffett Cancer Center
|
9:10 a.m. – 12:20 p.m. |
Biomarker Developmental Laboratories |
9:10 a.m. – 9:25 a.m. 9:25 a.m. – 9:30 a.m. Q&A |
Prostate
|
9:30 a.m. – 9:45 a.m. 9:45 a.m. – 9:50 a.m. Q&A |
Prostate
|
9:50 a.m. – 10:05 a.m. 10:05 a.m. – 10:10 a.m. Q&A |
Prostate
|
10:10 a.m. – 10:25 a.m. 10:25 a.m. – 10:30 a.m. Q&A |
Ovary
|
10:30 a.m. – 10:40 a.m. |
Break |
10:40 a.m. – 10:55 a.m. 10:55 a.m. – 11:00 a.m. Q&A |
Breast
|
11:00 a.m. – 11:15 a.m. 11:15 a.m. – 11:20 a.m. Q&A |
Lung and Ovary
|
11:20 a.m. – 11:35 a.m. 11:35 a.m. – 11:40 a.m. Q&A |
Lung
|
11:40 a.m. – 11:55 a.m. 11:55 a.m. – 12:00 p.m. Q&A |
Lung
|
12:00 p.m. – 12:15 p.m. 12:15p.m. – 12:20 p.m. Q&A |
GI/Colon
|
12:20 p.m. – 2:15 p.m. |
Lunch (On Your Own) (then 15 minute transition time to get to to the various collaborative group meetings') |
12:20 p.m. – 2:15 p.m. |
Executive Committee Meeting (closed)
|
2:30 p.m. – 5:45 p.m. |
Collaborative Group Meetings
|
6:00 p.m. – 8:00 p.m. |
Early Career Investigator Poster Session/Networking Room: Truhlsen Events Center Foyer |
8:00 p.m. |
Adjourn for the Day |
Wednesday, September 25, 2024 (7:00 a.m. – 6:45p.m.)
Central Daylight Time | Agenda Item |
---|---|
7:00 a.m. – 8:00 a.m. |
Sign-in: Room: Truhlsen Events Center Foyer General Session: Truhlsen Events Center Room 1001 A |
8:00 a.m. – 9:30 a.m. |
Early Onset Cancers |
8:00 a.m. – 8:20 a.m. |
Early Onset Breast Cancer
|
8:20 a.m. – 8:40 a.m. |
Updates in Early Onset Colorectal Cancer
|
8:40 a.m. – 9:00 a.m. |
Overview of Increasing Prevalence
|
9:00 a.m. – 9:30 a.m. |
Q&A |
9:30 a.m. – 9:40 a.m. |
Break |
9:40 a.m. – 11:40 a.m. |
Making Clinical Biomarker Assays for the CLIA Certified Lab: A Practical Guide |
9:40 a.m. – 9:55 a.m. 9:55 a.m. – 10:00 a.m. Q&A |
How to Setup a CLIA Certified Lab for Cancer Biomarker Testing
|
10:00 a.m. – 10:15 a.m. 10:15 a.m. – 10:20 a.m. Q&A |
Design and Development of Clinical Biomarker Tests for a CLIA Lab
|
10:20 a.m. – 10:35 a.m. 10:35 a.m. – 10:40 a.m. Q&A |
Use of RUOs on Clinical Platforms to Support Early Trials in Clinical Evidence Expansion
|
10:40 a.m. – 10:55 a.m 10:55 a.m. – 11:00 a.m. Q&A |
Case Study and Real-world Applications
|
11:00 a.m. – 11:15 a.m. 11:15 a.m. – 11:20 a.m. Q&A |
FDA Clearance of AI Devices for Medical Images
|
11:20 a.m. – 11:40 a.m. |
Panel Discussion Chair: Andy Hoofnagle, MD, PhD, University of Washington |
11:40 a.m. – 12:30 p.m. |
Discussion of the Cancer Biomarkers AI and Bioinformatics Workshop, August 13–15, 2024
|
12:30 p.m. – 12:40 p.m. |
Q & A |
12:40 p.m. – 2:00 p.m. |
Lunch (On Your Own) |
2:00 p.m. – 3:20 p.m. |
Collaborative Group Updates |
2:00 p.m. – 2:15 p.m. 2:15 p.m. – 2:20 p.m. Q&A |
Breast and Gynecological Cancers
|
2:20 p.m. – 2:35 p.m. 2:35 p.m. – 2:40 p.m. Q&A |
Lung and Upper Aerodigestive Cancers
|
2:40 p.m. – 2:55 p.m. 2:55 p.m. – 3:00 p.m. Q&A |
Prostate and Urologic Cancers
|
3:00 p.m. – 3:15 p.m. 3:15 p.m. – 3:20 p.m. Q&A |
Gastrointestinal and Associated Cancers
|
3:20 p.m. – 3:50 p.m. |
Update on EDRN Liver Clinical Utility Trial (TRACER)
|
3:50 p.m. – 4:20 p.m. |
Break |
4:20 p.m. – 5:20 p.m. |
Round Table Discussions Round Table 1: Spatiomics & Digital Pathology Room: Sorrel Room 1005: 619 S 42nd St, Omaha, NE 68198
Round Table 2: Proteogenomics Room: Sorrel Room 2014: 619 S 42nd St, Omaha, NE 68198
Round Table 3: Virus Related Cancers Room: Sorrel Room 2001: 619 S 42nd St, Omaha, NE 68198
Round Table 4: Academic Industrial Partnerships Room: Truhlsen Events Center Room 1001 A: 619 S 42nd St, Omaha, NE 68198
|
5:20 p.m. – 5:40 p.m. |
Transition to Truhlsen Events Center, Room 1001 A for Summary of Round Table Discussions |
5:40 p.m. – 6:40 p.m. |
Summary of Round Table Discussions: Room: Truhlsen Events Center, Room 1001 A: 619 S 42nd St, Omaha, NE 68198 Round Table 1: Spatiomics & Digital Pathology
Round Table 2: Proteogenomics
Round Table 3: Virus Related Cancers
Round Table 4: Academic Industrial Partnerships
|
6:40 p.m. – 6:45 p.m. |
Closing Remarks
|
6:45 p.m. |
EDRN Steering Committee Meeting Adjourned |